Encysive Pharmaceuticals Inc.

Data on Thelin Presented at the European Society of Cardiology Annual Congress

Houston (ots/PRNewswire) - - Abstract Presented on Extension Data From STRIDE-1 Trial in Pulmonary Arterial Hypertension Encysive Pharmaceuticals (Nasdaq: ENCY) today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich. ...